|
|||||
|
|
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression |
|
| Authors: | Thomas Decaens Carlo Barone Eric Assenat Martin Wermke Angelica Fasolo Philippe Merle Jean-Frdric Blanc Vronique Grando Angelo Iacobellis Erica Villa Joerg Trojan Josef Straub Rolf Bruns Karin Berghoff Juergen Scheele Eric Raymond Sandrine Faivre |
| Abstract: | |
| Keywords: | |